HAIM
TRIB

Hunter Associates Investment Management’s Trinity Biotech TRIB Stock Holding History

Hunter Associates Investment Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$251K Buy
22,040
+4,166
+23% +$77.1K 0.03% 266
2026
Q1 		$292K Buy
17,874
+320
+2% +$7.06K 0.04% 236
2025
Q4 		$417K Buy
17,554
+1,317
+8% +$38.8K 0.06% 195
2025
Q3 		$502K Buy
16,237
+1,640
+11% +$51.7K 0.07% 184
2025
Q2 		$284K Buy
14,597
+2,093
+17% +$42K 0.04% 223
2025
Q1 		$214K Sell
12,504
-116
-0.9% -$2.75K 0.03% 233
2024
Q4 		$334K Buy
12,620
+626
+5% +$25.1K 0.05% 200
2024
Q3 		$390K Buy
11,994
+870
+8% +$58.8K 0.06% 194
2024
Q2 		$714K Buy
11,124
+530
+5% +$30.9K 0.12% 147
2024
Q1 		$644K Sell
10,594
-245
-2% -$17.2K 0.11% 158
2023
Q4 		$700K Sell
10,839
-710
-6% -$50.8K 0.13% 147
2023
Q3 		$1.26M Buy
11,549
+56
+0.5% +$6.88K 0.26% 93
2023
Q2 		$1.66M Sell
11,493
-341
-3% -$49.5K 0.32% 69
2023
Q1 		$1.68M Sell
11,834
-324
-3% -$50.1K 0.36% 67
2022
Q4 		$1.81M Buy
12,158
+177
+1% +$32.2K 0.44% 62
2022
Q3 		$1.91M Sell
11,981
-76
-0.6% -$14.7K 0.49% 53
2022
Q2 		$2.2M Sell
12,057
-4,024
-25% -$737K 0.54% 51
2022
Q1 		$2.56M Buy
16,081
+840
+6% +$145K 0.82% 31
2021
Q4 		$3.27M Buy
15,241
+1,268
+9% +$360K 0.94% 26
2021
Q3 		$4.53M Buy
13,973
+268
+2% +$94.3K 1.45% 18
2021
Q2 		$6.04M Buy
13,705
+2,752
+25% +$1.37M 1.88% 14
2021
Q1 		$6.18M Sell
10,953
-258
-2% -$186K 1.43% 19
2020
Q4 		$6.41M Sell
11,211
-233
-2% -$116K 1.58% 17
2020
Q3 		$3.47M Buy
11,444
+337
+3% +$117K 0.96% 28
2020
Q2 		$3.63M Buy
11,107
+714
+7% +$163K 1.08% 26
2020
Q1 		$1.72M Buy
10,393
+530
+5% +$83.2K 0.66% 38
2019
Q4 		$1.53M Sell
9,863
-62
-0.6% -$8.84K 0.47% 55
2019
Q3 		$1.8M Buy
9,925
+364
+4% +$94.9K 0.62% 43
2019
Q2 		$2.37M Buy
9,561
+2,370
+33% +$846K 0.81% 33
2019
Q1 		$3.07M Buy
7,191
+700
+11% +$289K 1.08% 24
2018
Q4 		$2.23M Buy
6,491
+1,003
+18% +$465K 0.91% 29
2018
Q3 		$3.29M Buy
5,488
+326
+6% +$213K 1.14% 22
2018
Q2 		$3.87M Buy
5,162
+179
+4% +$129K 1.4% 21
2018
Q1 		$3.85M Buy
4,983
+242
+5% +$198K 1.44% 22
2017
Q4 		$3.63M Buy
4,741
+468
+11% +$362K 1.34% 22
2017
Q3 		$3.6M Buy
4,273
+276
+7% +$231K 1.4% 24
2017
Q2 		$3.6M Buy
3,997
+899
+29% +$764K 1.46% 22
2017
Q1 		$2.77M Buy
3,098
+321
+12% +$301K 1.17% 28
2016
Q4 		$2.88M Buy
2,777
+292
+12% +$302K 1.23% 26
2016
Q3 		$4.93M Buy
2,485
+707
+40% +$1.32M 2.12% 12
2016
Q2 		$3.02M Buy
1,778
+1,001
+129% +$1.69M 1.31% 25
2016
Q1 		$1.36M Buy
777
+570
+275% +$908K 0.62% 45
2015
Q4 		$365K Buy
207
+125
+152% +$221K 0.16% 107
2015
Q3 		$141K Sell
82
-5
-6% -$12.1K 0.07% 137
2015
Q2 		$235K Hold
87
– – 0.1% 131
2015
Q1 		$250K Buy
87
+20
+30% +$55.5K 0.1% 129
2014
Q4 		$175K Hold
67
– – 0.07% 145
2014
Q3 		$183K Buy
+67
New +$218K 0.07% 142

Other funds holding TRIB

WN
Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Hunter Associates Investment Management's TRIB Position: Q2 2026 in Review

Hunter Associates Investment Management increased its Trinity Biotech (TRIB) stake by 23% in Q2 2026, buying an estimated $77.1K and bringing the position to 22,040 shares worth $251K. The position accounts for 0.03% of the portfolio, ranked #266.

Hunter Associates Investment Management first reported a position in TRIB in Q3 2014 and has held it in 48 quarters since. The position peaked at $6.41M in Q4 2020. 8 funds tracked by Wall St. Rank hold TRIB as of Q2 2026.

  • Hunter Associates Investment Management held 22,040 shares of Trinity Biotech worth $251K as of Q2 2026.
  • Hunter Associates Investment Management bought 4,166 Trinity Biotech shares in Q2 2026, an estimated $77.1K.
  • Trinity Biotech made up 0.03% of Hunter Associates Investment Management's portfolio in Q2 2026, its #266 holding.
  • Hunter Associates Investment Management first reported a position in Trinity Biotech in Q3 2014 and has held it in 48 quarters since.
  • Hunter Associates Investment Management's Trinity Biotech position peaked at $6.41M in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2026.

Based on Hunter Associates Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.